EU Matrix Atlas › News
EU Policy News · ATLAS

EFSA Reveals New Veterinary Residue Monitoring Strategies to Enhance Animal Health Oversight

Technical Report · 2026-02-10

The European Food Safety Authority (EFSA) has rolled out its latest intentions to tighten the reins on veterinary medicinal product residues in live animals and animal products, a move likely to tick multiple stakeholders. Farmers, veterinarians, consumer safety groups, and national food safety authorities will all be watching closely, anticipating the repercussions of EFSA’s enhanced surveillance plans announced on February 10, 2026.

This information comes from EFSA's "Report for 2024 on the results from the monitoring of residues of veterinary medicinal products in live animals and animal products," a technical report published by the agency’s scientific team dedicated to animal health and welfare data.

The document is a detailed technical report rather than new legislation, aimed at collating, analyzing, and presenting data from the 2024 residue monitoring efforts across Member States. It combines factual results with recommendations for improving data systems under the SIGMA initiative—a structured animal health and welfare data collection framework. While no binding legal changes are prescribed, EFSA’s insights highlight potential directions for regulatory evaluation and policy refinement.

EFSA’s report reaffirms a regulatory tilt towards strengthening residue surveillance while advocating the enhancement of harmonized data collection mechanisms. This involves expanding the SIGMA framework’s scope and improving the granularity and timeliness of animal health data. The report endorses increased cooperation between EU Member States’ authorities rather than pushing for broader EU legislative powers, thus balancing enhanced oversight with respect for national sovereignty in food safety enforcement.

For farmers and veterinary pharmaceutical producers, improved data collection and monitoring mean stricter compliance pressures and potential operational adjustments to reduce residue risks. Conversely, consumer protection and food safety advocates will welcome the bolstered focus on minimizing risks from veterinary drug residues. National authorities tasked with food chain safety will face quantitative and qualitative demands to upgrade surveillance infrastructure but gain clearer guidance on data harmonization.

This report serves as a continuation of ongoing monitoring efforts and data collection improvements within the EU food safety system. The European Commission and Member States’ competent authorities are expected to review EFSA's findings carefully, potentially translating them into legislative updates or reinforced compliance frameworks to shape future veterinary residue controls.

Open this story on Atlas →
© EU Matrix · atlas.eumatrix.app · Original analysis by EU Matrix. Sign in for the full policy intelligence platform.